Citations (161)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Jerome H. Check & Diane L. Check. (2023) The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years. Expert Review of Endocrinology & Metabolism 18:1, pages 5-18.
Read now
Read now
Yayun Liang, Sandy Goyette & Salman M Hyder. (2017) Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells. Breast Cancer: Targets and Therapy 9, pages 487-494.
Read now
Read now
Yuval Yung, Ettie Maman, Libby Ophir, Nirit Rubinstein, Eran Barzilay, Gil M. Yerushalmi & Ariel Hourvitz. (2014) Progesterone antagonist, RU486, represses LHCGR expression and LH/hCG signaling in cultured luteinized human mural granulosa cells. Gynecological Endocrinology 30:1, pages 42-47.
Read now
Read now
Caroline Diep, Nathan Charles, C. Blake Gilks, Steve Kalloger, Peter Argenta & Carol A. Lange. (2013) Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells. Cell Cycle 12:9, pages 1433-1449.
Read now
Read now
Christy R. Hagan, Tarah M. Regan, Gwen E. Dressing & Carol A. Lange. (2011) ck2-Dependent Phosphorylation of Progesterone Receptors (PR) on Ser81 Regulates PR-B Isoform-Specific Target Gene Expression in Breast Cancer Cells. Molecular and Cellular Biology 31:12, pages 2439-2452.
Read now
Read now
Andrea R Daniel, Christy R Hagan & Carol A Lange. (2011) Progesterone receptor action: defining a role in breast cancer. Expert Review of Endocrinology & Metabolism 6:3, pages 359-369.
Read now
Read now
Zeynep Madak-Erdogan, Mathieu Lupien, Fabio Stossi, Myles Brown & Benita S. Katzenellenbogen. (2011) Genomic Collaboration of Estrogen Receptor α and Extracellular Signal-Regulated Kinase 2 in Regulating Gene and Proliferation Programs. Molecular and Cellular Biology 31:1, pages 226-236.
Read now
Read now
Rooshdiya Z. Karim, Richard A. Scolyer, Gary M. Tse, Puay-Hoon Tan, Thomas C. Putti & C. Soon Lee. (2009) Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours. Pathology 41:2, pages 105-117.
Read now
Read now
Articles from other publishers (153)
Fahmida Rasha, Geetha Priya Boligala, Mingxiao V. Yang, Dalia Martinez-Marin, Isabel Castro-Piedras, Kathryn Furr, Annie Snitman, Sonia Y. Khan, Luis Brandi, Maribel Castro, Hafiz Khan, Nusrat Jahan, Sharilyn Almodovar, Michael W. Melkus, Kevin Pruitt & Rakhshanda Layeequr Rahman. (2023) Dishevelled 2 regulates cancer cell proliferation and T cell mediated immunity in HER2-positive breast cancer. BMC Cancer 23:1.
Crossref
Crossref
Christos Velesiotis, Marinos Kanellakis & Demitrios H. Vynios. (2022) Steviol glycosides affect functional properties and macromolecular expression of breast cancer cells. IUBMB Life 74:10, pages 1012-1028.
Crossref
Crossref
Shuangyi Cai, Thomas Hu, Mythreye Venkatesan, Mayar Allam, Frank Schneider, Suresh S. Ramalingam, Shi-Yong Sun & Ahmet F. Coskun. (2022) Multiplexed protein profiling reveals spatial subcellular signaling networks. iScience 25:9, pages 104980.
Crossref
Crossref
May-Britt Firnau & Angela Brieger. (2022) CK2 and the Hallmarks of Cancer. Biomedicines 10:8, pages 1987.
Crossref
Crossref
Franck Mauvais-Jarvis, Carol A Lange & Ellis R Levin. (2022) Membrane-Initiated Estrogen, Androgen, and Progesterone Receptor Signaling in Health and Disease. Endocrine Reviews 43:4, pages 720-742.
Crossref
Crossref
Claudia Bello-Alvarez, Carmen J. Zamora-Sánchez & Ignacio Camacho-Arroyo. (2022) Rapid Actions of the Nuclear Progesterone Receptor through cSrc in Cancer. Cells 11:12, pages 1964.
Crossref
Crossref
Na Young Kim, Chakrabhavi Dhananjaya Mohan, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Gautam Sethi, Kanchugarakoppal S. Rangappa & Kwang Seok Ahn. (2022) Euphorbiasteroid Abrogates EGFR and Wnt/β-Catenin Signaling in Non-Small-Cell Lung Cancer Cells to Impart Anticancer Activity. Molecules 27:12, pages 3824.
Crossref
Crossref
Emma Grant, Fatma A. Bucklain, Lucy Ginn, Peter Laity, Barbara Ciani & Helen E. Bryant. (2022) Progesterone receptor expression contributes to gemcitabine resistance at higher ECM stiffness in breast cancer cell lines. PLOS ONE 17:5, pages e0268300.
Crossref
Crossref
Aloran Mazumder, Stephen Shiao & Svasti Haricharan. (2021) HER2 Activation and Endocrine Treatment Resistance in HER2-negative Breast Cancer. Endocrinology 162:10.
Crossref
Crossref
Yan Zou, Le Pan, Yi Shen, Xiang Wang, Chenxing Huang, Hao Wang, Xuejuan Jin, Chao Yin, Ying Wang, Jianguo Jia, Juying Qian, Yunzeng Zou, Hui Gong & Junbo Ge. (2021) Cardiac Wnt5a and Wnt11 promote fibrosis by the crosstalk of FZD5 and EGFR signaling under pressure overload. Cell Death & Disease 12:10.
Crossref
Crossref
Wojciech Kowalczyk, Grzegorz Waliszczak, Robert Jach & Joanna Dulińska-Litewka. (2021) Steroid Receptors in Breast Cancer: Understanding of Molecular Function as a Basis for Effective Therapy Development. Cancers 13:19, pages 4779.
Crossref
Crossref
Sailaja Kamaraju, Amy M Fowler, Elizabeth Weil, Kari B Wisinski, Thu H Truong, Martin Lehr, Lubna N Chaudhary, Yee Chung Cheng, Christopher R Chitambar, Hallgeir Rui, Douglas Yee & Carol Lange. (2021) Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer. Endocrinology 162:8.
Crossref
Crossref
Christina N. Cordeiro Mitchell, Md Soriful Islam, Sadia Afrin, Joshua Brennan, Kevin J. Psoter & James H. Segars. (2021) Mechanical stiffness augments ligand-dependent progesterone receptor B activation via MEK 1/2 and Rho/ROCK–dependent signaling pathways in uterine fibroid cells. Fertility and Sterility 116:1, pages 255-265.
Crossref
Crossref
Laura J Mauro, Megan I Seibel, Caroline H Diep, Angela Spartz, Carlos Perez Kerkvliet, Hari Singhal, Elizabeth M Swisher, Lauren E Schwartz, Ronny Drapkin, Siddharth Saini, Fatmata Sesay, Larisa Litovchick & Carol A Lange. (2021) Progesterone Receptors Promote Quiescence and Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models. The Journal of Clinical Endocrinology & Metabolism 106:7, pages 1929-1955.
Crossref
Crossref
Lauryn R Werner, Katelin A Gibson, Merit L Goodman, Dominika E Helm, Katherine R Walter, Sean M Holloran, Gloria M Trinca, Richard C Hastings, Howard H Yang, Ying Hu, Junping Wei, Gangjun Lei, Xiao-Yi Yang, Rashna Madan, Alfredo A Molinolo, Mary A Markiewicz, Prabhakar Chalise, Margaret L Axelrod, Justin M Balko, Kent W Hunter, Zachary C Hartman, Carol A Lange & Christy R Hagan. (2021) Progesterone promotes immunomodulation and tumor development in the murine mammary gland. Journal for ImmunoTherapy of Cancer 9:5, pages e001710.
Crossref
Crossref
Saucedo-Correa Germán, Bravo-Patiño, A., Nuñez-Anita, R.E., Oviedo-Boyso Javier, Valdez-Alarcon Juan José & Baizabal-Aguirre Víctor Manuel. (2021) The Notch Signaling Pathway and Breast Cancer: The Importance of Balance and Cellular Self-Control. Current Signal Transduction Therapy 16:1, pages 38-50.
Crossref
Crossref
George Sflomos, Laura Battista, Patrick Aouad, Fabio De Martino, Valentina Scabia, Athina Stravodimou, Ayyakkannu Ayyanan, Assia Ifticene‐Treboux, Philipp Bucher, Maryse Fiche, Giovanna Ambrosini & Cathrin Brisken. (2021) Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1. EMBO Molecular Medicine 13:3.
Crossref
Crossref
Gurjinder Singh, Md Mehedi Hossain, Aadil Qadir Bhat, Mir Owais Ayaz, Nasima Bano, Rafiqa Eachkoti & Mohd Jamal Dar. (2021) Identification of a cross-talk between EGFR and Wnt/beta-catenin signaling pathways in HepG2 liver cancer cells. Cellular Signalling 79, pages 109885.
Crossref
Crossref
Margeaux Wetendorf, Rong Li, San-Pin Wu, Jian Liu, Chad J. Creighton, Tianyuan Wang, Kyathanahalli S. Janardhan, Cynthia J. Willson, Rainer B. LanzBruce D. Murphy, John P. LydonFrancesco J. DeMayo. (2020) Constitutive expression of progesterone receptor isoforms promotes the development of hormone-dependent ovarian neoplasms. Science Signaling 13:652.
Crossref
Crossref
Md Soriful Islam, Sadia Afrin, Sara Isabel Jones & James Segars. (2020) Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility. Endocrine Reviews 41:5.
Crossref
Crossref
K. Izrailbekova. (2020) STEM CELLS IN BREAST CANCER: THE ROLE OF GENDER STEROID RECEPTORS. EurasianUnionScientists 1:8(77), pages 11-20.
Crossref
Crossref
Lucie Malbeteau, Coralie Poulard, Cécile Languilaire, Ivan Mikaelian, Frédéric Flamant, Muriel Le Romancer & Laura Corbo. (2020) PRMT1 Is Critical for the Transcriptional Activity and the Stability of the Progesterone Receptor. iScience 23:6, pages 101236.
Crossref
Crossref
Olivia McGinn, Ashley V. Ward, Lynsey M. Fettig, Duncan Riley, Joshua Ivie, Kiran V. Paul, Peter Kabos, Jessica Finlay-Schultz & Carol A. Sartorius. (2020) Cytokeratin 5 alters β-catenin dynamics in breast cancer cells. Oncogene 39:12, pages 2478-2492.
Crossref
Crossref
Daniel L. Faden, Roberto Gomez-Casal, Diego Alvarado & Umamaheswar Duvvuri. (2019) Genomic Correlates of Exceptional Response to ErbB3 Inhibition in Head and Neck Squamous Cell Carcinoma. JCO Precision Oncology:3, pages 1-5.
Crossref
Crossref
Mauro E. Cenciarini & Cecilia J. Proietti. (2019) Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation. Steroids 152, pages 108503.
Crossref
Crossref
Pia Giovannelli, Marzia Di Donato, Giovanni Galasso, Erika Di Zazzo, Nicola Medici, Antonio Bilancio, Antimo Migliaccio & Gabriella Castoria. (2019) Breast cancer stem cells: the role of sex steroid receptors. World Journal of Stem Cells 11:9, pages 594-603.
Crossref
Crossref
Sarah L. Roche, Oksana Kutsyr, Nicolás Cuenca & Thomas G. Cotter. (2019) Norgestrel, a Progesterone Analogue, Promotes Significant Long-Term Neuroprotection of Cone Photoreceptors in a Mouse Model of Retinal Disease. Investigative Opthalmology & Visual Science 60:8, pages 3221.
Crossref
Crossref
Tam D. NguyenJames DavisRoelle A. EugenioYingguang Liu. (2019) Female Sex Hormones Activate Human Endogenous Retrovirus Type K Through the OCT4 Transcription Factor in T47D Breast Cancer Cells. AIDS Research and Human Retroviruses 35:3, pages 348-356.
Crossref
Crossref
Thu H Truong, Amy R Dwyer, Caroline H Diep, Hsiangyu Hu, Kyla M Hagen & Carol A Lange. (2019) Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem Cell and Proliferative Breast Cancer Cell Fates. Endocrinology 160:2, pages 430-446.
Crossref
Crossref
Min Yao, Wei Fang, Curtis Smart, Qingting Hu, Shixia Huang, Nehemiah Alvarez, Patrick Fields & Nikki Cheng. (2019) CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation. Molecular Cancer Research 17:2, pages 604-617.
Crossref
Crossref
Lei Liu, Yi Yang, Shihua Liu, Tianyu Tao, Junchao Cai, Jueheng Wu, Hongyu Guan, Xun Zhu, Zhenjian He, Jun Li, Erwei Song, Musheng Zeng & Mengfeng Li. (2018) EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression. Oncogene 38:5, pages 747-764.
Crossref
Crossref
Caroline A Lamb, Victoria T Fabris, Britta M Jacobsen, Alfredo Molinolo & Claudia Lanari. (2018) Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer. Endocrine-Related Cancer 25:12, pages R605-R624.
Crossref
Crossref
Jürgen Dittmer. (2018) Breast cancer stem cells: Features, key drivers and treatment options. Seminars in Cancer Biology 53, pages 59-74.
Crossref
Crossref
Meghan S Perkins, Renate Louw-du Toit & Donita Africander. (2018) Hormone therapy and breast cancer: emerging steroid receptor mechanisms. Journal of Molecular Endocrinology 61:4, pages R133-R160.
Crossref
Crossref
Tarah M. Regan Anderson, Shihong Ma, Carlos Perez Kerkvliet, Yan Peng, Taylor M. Helle, Raisa I. Krutilina, Ganesh V. Raj, John A. Cidlowski, Julie H. Ostrander, Kathryn L. Schwertfeger, Tiffany N. Seagroves & Carol A. Lange. (2018) Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF–driven Signaling Axis. Molecular Cancer Research 16:11, pages 1761-1772.
Crossref
Crossref
Derek A. Schreihofer, Phong Duong & Rebecca L. Cunningham. (2018) N-terminal truncations in sex steroid receptors and rapid steroid actions. Steroids 133, pages 15-20.
Crossref
Crossref
Dimitrios Papadopoulos, Mazen Shihan & Georgios Scheiner-Bobis. (2018) Physiological implications of DHEAS-induced non-classical steroid hormone signaling. The Journal of Steroid Biochemistry and Molecular Biology 179, pages 73-78.
Crossref
Crossref
Mark D. Aupperlee, Anastasia Kariagina, Nicole Zaremba, Marc D. Basson, Richard C. Schwartz & Sandra Z. Haslam. (2018) The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors. Translational Oncology 11:2, pages 518-527.
Crossref
Crossref
R. Domínguez-Ordóñez, M. Garcia-Juárez, F.J. Lima-Hernández, P. Gómora-Arrati, E. Domínguez-Salazar, J.D. Blaustein, A.M. Etgen & O. González-Flores. (2018) Lordosis facilitated by GPER-1 receptor activation involves GnRH-1, progestin and estrogen receptors in estrogen-primed rats. Hormones and Behavior 98, pages 77-87.
Crossref
Crossref
Katherine A. Leehy, Thu H. Truong, Laura J. Mauro & Carol A. Lange. (2018) Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models. The Journal of Steroid Biochemistry and Molecular Biology 176, pages 88-93.
Crossref
Crossref
Katherine R. Walter, Merit L. Goodman, Hari Singhal, Jade A. Hall, Tianbao Li, Sean M. Holloran, Gloria M. Trinca, Katelin A. Gibson, Victor X. Jin, Geoffrey L. Greene & Christy R. Hagan. (2017) Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer. Molecular Cancer Research 15:10, pages 1331-1340.
Crossref
Crossref
Jessica Finlay-Schultz, Austin E. Gillen, Heather M. Brechbuhl, Joshua J. Ivie, Shawna B. Matthews, Britta M. Jacobsen, David L. Bentley, Peter Kabos & Carol A. Sartorius. (2017) Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III. Cancer Research 77:18, pages 4934-4946.
Crossref
Crossref
Dina Polosukhina, Harold D. Love, Hernan Correa, Zengliu Su, Kimberly B. Dahlman, William Pao, Harold L. Moses, Carlos L. Arteaga, Harold N. LovvornIIIIII, Roy Zent & Peter E. Clark. (2017)
Functional
KRAS
mutations and a potential role for PI3K/AKT activation in Wilms tumors
. Molecular Oncology 11:4, pages 405-421.
Crossref
Crossref
RuiQi Chen, Yue Yu & Xuesen Dong. (2017) Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology 166, pages 91-96.
Crossref
Crossref
Jason S. Carroll, Theresa E. Hickey, Gerard A. Tarulli, Michael Williams & Wayne D. Tilley. (2016) Deciphering the divergent roles of progestogens in breast cancer. Nature Reviews Cancer 17:1, pages 54-64.
Crossref
Crossref
Dominika Piasecka, Kamila Kitowska, Dominika Czaplinska, Kamil Mieczkowski, Magdalena Mieszkowska, Lukasz Turczyk, Andrzej C. Skladanowski, Anna J. Zaczek, Wojciech Biernat, Radzislaw Kordek, Hanna M. Romanska & Rafal Sadej. (2016) Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells. Oncotarget 7:52, pages 86011-86025.
Crossref
Crossref
Ellis R. Levin & Stephen R. Hammes. (2016) Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors. Nature Reviews Molecular Cell Biology 17:12, pages 783-797.
Crossref
Crossref
Rachael S. Allen, Iqbal Sayeed, Yuliya Oumarbaeva, Katherine C. Morrison, Paul H. Choi, Machelle T. Pardue & Donald G. Stein. (2016) Progesterone treatment shows greater protection in brain vs. retina in a rat model of middle cerebral artery occlusion: Progesterone receptor levels may play an important role. Restorative Neurology and Neuroscience 34:6, pages 947-963.
Crossref
Crossref
Caroline H. Diep, Hannah Ahrendt & Carol A. Lange. (2016) Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes. Steroids 114, pages 48-58.
Crossref
Crossref
Francesca De Amicis, Carmela Guido, Marta Santoro, Francesca Giordano, Ada Donà, Pietro Rizza, Michele Pellegrino, Ida Perrotta, Daniela Bonofiglio, Diego Sisci, Maria Luisa Panno, Donatella Tramontano, Saveria Aquila & Sebastiano Andò. (2016) Ligand activated progesterone receptor B drives autophagy-senescence transition through a Beclin-1/Bcl-2 dependent mechanism in human breast cancer cells. Oncotarget 7:36, pages 57955-57969.
Crossref
Crossref
Heng-Jia Liu, Lisa M. Ooms, Nuthasuda Srijakotre, Joey Man, Jessica Vieusseux, JoAnne E. Waters, Yue Feng, Charles G. Bailey, John E.J. Rasko, John T. Price & Christina A. Mitchell. (2016) PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling. Journal of Biological Chemistry 291:33, pages 17258-17270.
Crossref
Crossref
Sornsawan Kawprasertsri, Richard J. Pietras, Diana C. Marquez-Garban & Viroj Boonyaratanakornkit. (2016) Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells. Cancer Letters 374:2, pages 279-291.
Crossref
Crossref
Katherine A Leehy, Tarah M Regan Anderson, Andrea R Daniel, Carol A Lange & Julie H Ostrander. (2016) Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer. Journal of Molecular Endocrinology 56:3, pages R99-R114.
Crossref
Crossref
Tarah M. Regan Anderson, Shi Hong Ma, Ganesh V. Raj, John A. Cidlowski, Taylor M. Helle, Todd P. Knutson, Raisa I. Krutilina, Tiffany N. Seagroves & Carol A. Lange. (2016) Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer. Cancer Research 76:6, pages 1653-1663.
Crossref
Crossref
Caroline H. Diep, Todd P. Knutson & Carol A. Lange. (2016) Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming. Molecular Cancer Research 14:2, pages 141-162.
Crossref
Crossref
Alice C. Wyse Jackson, Sarah L. Roche, Ashleigh M. Byrne, Ana M. Ruiz-Lopez & Thomas G. Cotter. (2016) Progesterone receptor signalling in retinal photoreceptor neuroprotection. Journal of Neurochemistry 136:1, pages 63-77.
Crossref
Crossref
Claudia Cava, Gloria Bertoli & Isabella Castiglioni. (2015) Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential. BMC Systems Biology 9:1.
Crossref
Crossref
Nathalie Esber, Florian Le Billan, Michèle Resche-Rigon, Hugues Loosfelt, Marc Lombès & Nathalie Chabbert-Buffet. (2015) Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression. PLOS ONE 10:10, pages e0140795.
Crossref
Crossref
Cecilia J. Proietti, Franco Izzo, María Celeste Díaz Flaqué, Rosalía Cordo Russo, Leandro Venturutti, María Florencia Mercogliano, Mara De Martino, Viviana Pineda, Sergio Muñoz, Pablo Guzmán, Juan C. Roa, Roxana Schillaci & Patricia V. Elizalde. (2015) Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth. Molecular Endocrinology 29:10, pages 1468-1485.
Crossref
Crossref
Cathrin Brisken, Kathryn Hess & Rachel Jeitziner. (2015) Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis. Endocrinology 156:10, pages 3442-3450.
Crossref
Crossref
Heidi N. Hilton, J. Dinny Graham & Christine L. Clarke. (2015) Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?. Molecular Endocrinology 29:9, pages 1230-1242.
Crossref
Crossref
Jacques Bonneterre, Emilie Hutt, Jacques Bosq, J. Dinny Graham, Matthew A. Powell, Eric Leblanc, Keiichi Fujiwara, Thomas J. Herzog, Robert L. Coleman, Christine L. Clarke, Erard M. Gilles, Alexander A. Zukiwski & Bradley J. Monk. (2015) Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus. Gynecologic Oncology 138:3, pages 663-667.
Crossref
Crossref
Valerie A. Flores & Hugh S. Taylor. (2015) The Effect of Menopausal Hormone Therapies on Breast Cancer. Endocrinology and Metabolism Clinics of North America 44:3, pages 587-602.
Crossref
Crossref
Hany A Abdel-Hafiz & Kathryn B Horwitz. (2015) Role of epigenetic modifications in luminal breast cancer. Epigenomics 7:5, pages 847-862.
Crossref
Crossref
Jessica Finlay-Schultz & Carol A. Sartorius. (2015) Steroid Hormones, Steroid Receptors, and Breast Cancer Stem Cells. Journal of Mammary Gland Biology and Neoplasia 20:1-2, pages 39-50.
Crossref
Crossref
María Pilar Sánchez-Bailón, Annarica Calcabrini, Víctor Mayoral-Varo, Agnese Molinari, Kay-Uwe Wagner, Jesús Pérez Losada, Sergio Ciordia, Juan Pablo Albar & Jorge Martín-Pérez. (2015) Cyr61 as mediator of Src signaling in triple negative breast cancer cells. Oncotarget 6:15, pages 13520-13538.
Crossref
Crossref
Ashley M. Fortress, John D. Heisler & Karyn M. Frick. (2015) The mTOR and canonical Wnt signaling pathways mediate the mnemonic effects of progesterone in the dorsal hippocampus. Hippocampus 25:5, pages 616-629.
Crossref
Crossref
Caroline H Diep, Andrea R Daniel, Laura J Mauro, Todd P Knutson & Carol A Lange. (2015) Progesterone action in breast, uterine, and ovarian cancers. Journal of Molecular Endocrinology 54:2, pages R31-R53.
Crossref
Crossref
Maria Loreto Bravo, Mauricio P. Pinto, Ibeth Gonzalez, Barbara Oliva, Sumie Kato, Mauricio A. Cuello, Carol A. Lange & Gareth I. Owen. (2014) Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor. Endocrine 48:1, pages 309-320.
Crossref
Crossref
A R Daniel, A L Gaviglio, T P Knutson, J H Ostrander, A B D'Assoro, P Ravindranathan, Y Peng, G V Raj, D Yee & C A Lange. (2014) Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes. Oncogene 34:4, pages 506-515.
Crossref
Crossref
Shea A. Ford & George Blanck. (2015) Signal persistence and amplification in cancer development and possible, related opportunities for novel therapies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1855:1, pages 18-23.
Crossref
Crossref
Jorge Martín-Pérez, José Manuel García-Martínez, María Pilar Sánchez-Bailón, Víctor Mayoral-Varo & Annarica Calcabrini. 2015. Recent Advances in Prolactin Research. Recent Advances in Prolactin Research
163
188
.
Christy R Hagan & Carol A Lange. (2014) Molecular determinants of context-dependent progesterone receptor action in breast cancer. BMC Medicine 12:1.
Crossref
Crossref
Nicole L. Moore, Dean P. Edwards & Nancy L. Weigel. (2014) Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 144, pages 471-482.
Crossref
Crossref
Xia Fang, Pan Gu, Caicun Zhou, Aibin Liang, Shenxiang Ren, Fang Liu, Yu Zeng, Yunjin Wu, Yinmin Zhao, Binbin Huang, Zongmei Zhang & Xianghua Yi. (2014) β-Catenin overexpression is associated with gefitinib resistance in non-small cell lung cancer cells. Pulmonary Pharmacology & Therapeutics 28:1, pages 41-48.
Crossref
Crossref
Ellis R. Levin. (2014) Translating Extranuclear Steroid Receptor Signaling to Clinical Medicine. Hormones and Cancer 5:3, pages 140-145.
Crossref
Crossref
Todd P. Knutson & Carol A. Lange. (2014) Tracking progesterone receptor-mediated actions in breast cancer. Pharmacology & Therapeutics 142:1, pages 114-125.
Crossref
Crossref
M. Schumacher, C. Mattern, A. Ghoumari, J.P. Oudinet, P. Liere, F. Labombarda, R. Sitruk-Ware, A.F. De Nicola & R. Guennoun. (2014) Revisiting the roles of progesterone and allopregnanolone in the nervous system: Resurgence of the progesterone receptors. Progress in Neurobiology 113, pages 6-39.
Crossref
Crossref
Hanjun Li, Gaelle Spagnol, Naava Naslavsky, Steve Caplan & Paul L. Sorgen. (2014) Tyrosine phosphatase TC-PTP directly interacts with connexin43 to regulate gap junction intercellular communication. Journal of Cell Science.
Crossref
Crossref
Mazen Shihan, Ulrike Kirch & Georgios Scheiner-Bobis. (2013) Dehydroepiandrosterone sulfate mediates activation of transcription factors CREB and ATF-1 via a Gα11-coupled receptor in the spermatogenic cell line GC-2. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1833:12, pages 3064-3075.
Crossref
Crossref
Anastasia Kariagina, Jianwei Xie, Ingeborg M. Langohr, Razvan C. Opreanu, Marc D. Basson & Sandra Z. Haslam. (2013) Progesterone Stimulates Proliferation and Promotes Cytoplasmic Localization of the Cell Cycle Inhibitor p27 in Steroid Receptor Positive Breast Cancers. Hormones and Cancer 4:6, pages 381-390.
Crossref
Crossref
Anastasia Kariagina, Jianwei Xie, Ingeborg M. Langohr, Razvan C. Opreanu, Marc D. Basson & Sandra Z. Haslam. (2013) Progesterone Decreases Levels of the Adhesion Protein E-Cadherin and Promotes Invasiveness of Steroid Receptor Positive Breast Cancers. Hormones and Cancer 4:6, pages 371-380.
Crossref
Crossref
Afsaneh Barzi, Annika Medea Lenz, Melissa J. Labonte & Heinz-Josef Lenz. (2013) Molecular Pathways: Estrogen Pathway in Colorectal Cancer. Clinical Cancer Research 19:21, pages 5842-5848.
Crossref
Crossref
Christy R. Hagan, Todd P. Knutson & Carol A. Lange. (2013) A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells. Nucleic Acids Research 41:19, pages 8926-8942.
Crossref
Crossref
Lindsey S. Treviño & Nancy L. Weigel. (2013) Phosphorylation: a fundamental regulator of steroid receptor action. Trends in Endocrinology & Metabolism 24:10, pages 515-524.
Crossref
Crossref
Marcos García-Juárez, Carlos Beyer, Porfirio Gómora-Arrati, Raymundo Domínguez-Ordoñez, Francisco J. Lima-Hernández, José R. Eguibar, Yadira L. Galicia-Aguas, Anne M. Etgen & Oscar González-Flores. (2013) Lordosis facilitation by leptin in ovariectomized, estrogen-primed rats requires simultaneous or sequential activation of several protein kinase pathways. Pharmacology Biochemistry and Behavior 110, pages 13-18.
Crossref
Crossref
Nathan G. Kase. 2013. Altchek's Diagnosis and Management of Ovarian Disorders. Altchek's Diagnosis and Management of Ovarian Disorders
37
64
.
Rebecca Lee Yean Wong & Cheryl Lyn Walker. (2013) Molecular Pathways: Environmental Estrogens Activate Nongenomic Signaling to Developmentally Reprogram the Epigenome. Clinical Cancer Research 19:14, pages 3732-3737.
Crossref
Crossref
Lindsey S. Treviño, William E. Bingman3rd3rd, Dean P. Edwards & Weigel NL. (2013) The requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific. Steroids 78:6, pages 542-547.
Crossref
Crossref
Francesca De Amicis, Alessandra Russo, Paola Avena, Marta Santoro, Adele Vivacqua, Daniela Bonofiglio, Loredana Mauro, Saveria Aquila, Donatella Tramontano, Suzanne AW Fuqua & Sebastiano Andò. (2013)
In vitro mechanism for downregulation of
ER
‐α expression by epigallocatechin gallate in
ER
+/
PR
+ human breast cancer cells
. Molecular Nutrition & Food Research 57:5, pages 840-853.
Crossref
Crossref
Frank Z. StanczykJanet P. Hapgood, Sharon Winer & Daniel R. MishellJr.Jr.. (2013) Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical Effects. Endocrine Reviews 34:2, pages 171-208.
Crossref
Crossref
Eva Zeller, Katharina Hammer, Melissa Kirschnick & Albert Braeuning. (2013) Mechanisms of RAS/β-catenin interactions. Archives of Toxicology 87:4, pages 611-632.
Crossref
Crossref
Yao-Tsung Yeh, Chien-Wei Chang, Ren-Jie Wei & Shen-Nien Wang. (2013) Progesterone and Related Compounds in Hepatocellular Carcinoma: Basic and Clinical Aspects. BioMed Research International 2013, pages 1-9.
Crossref
Crossref
Akash Gupta, Rajeshwari Mehta, Fatouma Alimirah, Xinjian Peng, Genoveva Murillo, Ronald Wiehle & Rajendra G. Mehta. (2013) Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 133, pages 30-42.
Crossref
Crossref
Rocio Sampayo, Sol Recouvreux & Marina Simian. 2013. Hormones and Breast Cancer. Hormones and Breast Cancer
185
201
.
Ping Fan, Russell E. McDaniel, Helen R. Kim, Dionyssia Clagett, Bassem Haddad & V. Craig Jordan. (2012) Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines. European Journal of Cancer 48:18, pages 3488-3498.
Crossref
Crossref
Olivia Tania Hernández-Hernández, Tania Karina González-García & Ignacio Camacho-Arroyo. (2012) Progesterone receptor and SRC-1 participate in the regulation of VEGF, EGFR and Cyclin D1 expression in human astrocytoma cell lines. The Journal of Steroid Biochemistry and Molecular Biology 132:1-2, pages 127-134.
Crossref
Crossref
Jorge Diaz, Evelyn Aranda, Soledad Henriquez, Marisol Quezada, Estefanía Espinoza, Maria Loreto Bravo, Bárbara Oliva, Soledad Lange, Manuel Villalon, Marius Jones, Jan J Brosens, Sumie Kato, Mauricio A Cuello, Todd P Knutson, Carol A Lange, Lisette Leyton & Gareth I Owen. (2012) Progesterone promotes focal adhesion formation and migration in breast cancer cells through induction of protease-activated receptor-1. Journal of Endocrinology 214:2, pages 165-175.
Crossref
Crossref
Tamara Tanos, Lucia Jimenez Rojo, Pablo Echeverria & Cathrin Brisken. (2012) ER and PR signaling nodes during mammary gland development. Breast Cancer Research 14:4.
Crossref
Crossref
Justus Stenzig, Andreas Schweikert, Angelika Piasecki, Grit Höppner, Thomas Eschenhagen & Thomas Rau. (2012) Progesterone receptor variants associated with the PROGINS haplotype exhibit functional properties similar to those of wild-type progesterone receptor. Pharmacogenetics and Genomics 22:8, pages 629-641.
Crossref
Crossref
Claudia Lanari, Victoria Wargon, Paola Rojas & Alfredo A Molinolo. (2012) Antiprogestins in breast cancer treatment: are we ready?. Endocrine-Related Cancer 19:3, pages R35-R50.
Crossref
Crossref
Sunshine Daddario Axlund & Carol A. Sartorius. (2012) Progesterone regulation of stem and progenitor cells in normal and malignant breast. Molecular and Cellular Endocrinology 357:1-2, pages 71-79.
Crossref
Crossref
Christy R. Hagan, Andrea R. Daniel, Gwen E. Dressing & Carol A. Lange. (2012) Role of phosphorylation in progesterone receptor signaling and specificity. Molecular and Cellular Endocrinology 357:1-2, pages 43-49.
Crossref
Crossref
Jodie M. Fleming, Erika Ginsburg, Anita S. Goldhar, Joshua Plant & Barbara K. Vonderhaar. (2012) Progesterone Receptor Activates Msx2 Expression by Downregulating TNAP/Akp2 and Activating the Bmp Pathway in EpH4 Mouse Mammary Epithelial Cells. PLoS ONE 7:3, pages e34058.
Crossref
Crossref
Stephen R. Hammes & Ellis R. Levin. (2011) Minireview: Recent Advances in Extranuclear Steroid Receptor Actions. Endocrinology 152:12, pages 4489-4495.
Crossref
Crossref
Peggy Benad, Martina Rauner, Tilman D. Rachner & Lorenz C. Hofbauer. (2011) The anti-progestin RU-486 inhibits viability of MCF-7 breast cancer cells by suppressing WNT1. Cancer Letters 312:1, pages 101-108.
Crossref
Crossref
Peter E. Clark, Dina Polosukhina, Harold Love, Hernan Correa, Cheryl Coffin, Elizabeth J. Perlman, Mark de Caestecker, Harold L. Moses & Roy Zent. (2011) β-Catenin and K-RAS Synergize to Form Primitive Renal Epithelial Tumors with Features of Epithelial Wilms' Tumors. The American Journal of Pathology 179:6, pages 3045-3055.
Crossref
Crossref
Junaid A. KhanLarbi AmazitCatherine BellanceAnne Guiochon-Mantel, Marc Lombès & Hugues Loosfelt. (2011) p38 and p42/44 MAPKs Differentially Regulate Progesterone Receptor A and B Isoform Stabilization. Molecular Endocrinology 25:10, pages 1710-1724.
Crossref
Crossref
Y Li, J H Bavarva, Z Wang, J Guo, C Qian, S N Thibodeau, E A Golemis & W Liu. (2011) HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene 30:23, pages 2633-2643.
Crossref
Crossref
Alexander W. KrugLuminita H. PojogaGordon H. WilliamsGail K. Adler. (2011) Cell Membrane–Associated Mineralocorticoid Receptors?. Hypertension 57:6, pages 1019-1025.
Crossref
Crossref
María Cecilia Bottino, Juan Pablo Cerliani, Paola Rojas, Sebastián Giulianelli, Rocío Soldati, Carolina Mondillo, María Alicia Gorostiaga, Omar P. Pignataro, Juan Carlos Calvo, J. Silvio Gutkind, Panomwat Amornphimoltham, Alfredo A. Molinolo, Isabel A. Lüthy & Claudia Lanari. (2010) Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects. Breast Cancer Research and Treatment 126:3, pages 621-636.
Crossref
Crossref
Ellis R. Levin. (2011) Minireview: Extranuclear Steroid Receptors: Roles in Modulation of Cell Functions. Molecular Endocrinology 25:3, pages 377-384.
Crossref
Crossref
Anita S. Goldhar, Renqin Duan, Erika Ginsburg & Barbara K. Vonderhaar. (2011) Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP. Molecular and Cellular Endocrinology 335:2, pages 148-157.
Crossref
Crossref
Tiziana Giraldi, Pia Giovannelli, Marzia Di Donato, Gabriella Castoria, Antimo Migliaccio & Ferdinando Auricchio. (2010) Steroid signaling activation and intracellular localization of sex steroid receptors. Journal of Cell Communication and Signaling 4:4, pages 161-172.
Crossref
Crossref
Anastasia Kariagina, Jianwei Xie, Jeffrey R. Leipprandt & Sandra Z. Haslam. (2010) Amphiregulin Mediates Estrogen, Progesterone, and EGFR Signaling in the Normal Rat Mammary Gland and in Hormone-Dependent Rat Mammary Cancers. Hormones and Cancer 1:5, pages 229-244.
Crossref
Crossref
Paulina Wyrzykowska, Krystyna Stalińska, Mateusz Wawro, Jakub Kochan & Aneta Kasza. (2010) Epidermal growth factor regulates PAI-1 expression via activation of the transcription factor Elk-1. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1799:9, pages 616-621.
Crossref
Crossref
Oscar González-Flores, Carlos Beyer, Porfirio Gómora-Arrati, Marcos García-Juárez, Francisco J. Lima-Hernández, Alfonso Soto-Sánchez & Anne M. Etgen. (2010) A role for Src kinase in progestin facilitation of estrous behavior in estradiol-primed female rats. Hormones and Behavior 58:2, pages 223-229.
Crossref
Crossref
Lian Zuo, Wei Li & Shaojin You. (2010) Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway. Breast Cancer Research 12:3.
Crossref
Crossref
Shaila Mani & Wendy Portillo. (2010) Activation of progestin receptors in female reproductive behavior: Interactions with neurotransmitters. Frontiers in Neuroendocrinology 31:2, pages 157-171.
Crossref
Crossref
Antimo Migliaccio, Gabriella Castoria & Ferdinando Auricchio. 2010. Nuclear Receptors. Nuclear Receptors
365
379
.
Jacqueline Whyte, Orla Bergin, Alessandro Bianchi, Sara McNally & Finian Martin. (2009) Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Research 11:5.
Crossref
Crossref
Aaron K. Holley, Kelley K. Kiningham, Douglas R. Spitz, Dean P. Edwards, Jeffrey T. Jenkins & Michael R. Moore. (2009) Progestin stimulation of manganese superoxide dismutase and invasive properties in T47D human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 117:1-3, pages 23-30.
Crossref
Crossref
Andrea R. Daniel, Todd P. Knutson & Carol A. Lange. (2009) Signaling inputs to progesterone receptor gene regulation and promoter selectivity. Molecular and Cellular Endocrinology 308:1-2, pages 47-52.
Crossref
Crossref
Andrea R. Daniel & Carol A. Lange. (2009) Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells. Proceedings of the National Academy of Sciences 106:34, pages 14287-14292.
Crossref
Crossref
Charles E. Wood, Thomas C. Register & J. Mark Cline. (2008) Transcriptional profiles of progestogen effects in the postmenopausal breast. Breast Cancer Research and Treatment 114:2, pages 233-242.
Crossref
Crossref
Gwangil KimJi Young KimHee Jung AnHaeyoun KangTae Heon KimJung Yon ShimJin Hyung HeoHai Lin ParkYoung Kil Choi. (2009) The Loss of E-cadherin is Associated with the Epigenetic Alteration of CDH1 in Breast Cancer and it is also Associated with an Abnormal β-catenin Expression in Lobular Carcinoma. The Korean Journal of Pathology 43:5, pages 400.
Crossref
Crossref
M.J. Tetel & C.A. Lange. 2009. Hormones, Brain and Behavior. Hormones, Brain and Behavior
1439
1466
.
Zhuo Zhang, Rong Yang, Rong Zhou, Liang Li, Masahiro Sokabe & Ling Chen. (2009) Progesterone promotes the survival of newborn neurons in the dentate gyrus of adult male mice. Hippocampus, pages NA-NA.
Crossref
Crossref
O. González-Flores, A. M. Etgen, B. K. Komisaruk, P. Gómora-Arrati, A. Macias-Jimenez, F. J. Lima-Hernández, M. Garcia-Juárez & C. Beyer. (2008) Antagonists of the Protein Kinase A and Mitogen-Activated Protein Kinase Systems and of the Progestin Receptor Block the Ability of Vaginocervical/Flank-Perineal Stimulation to Induce Female Rat Sexual Behaviour. Journal of Neuroendocrinology 20:12, pages 1361-1367.
Crossref
Crossref
Gillian Murphy. (2008) The ADAMs: signalling scissors in the tumour microenvironment. Nature Reviews Cancer 8:12, pages 932-941.
Crossref
Crossref
Ellis R. Levin. (2008) Rapid signaling by steroid receptors. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 295:5, pages R1425-R1430.
Crossref
Crossref
Venkataraman Sriraman, Swati R. Modi, Yvonne Bodenburg, Larry A. Denner & Randall J. Urban. (2008) Identification of ERK and JNK as signaling mediators on protein kinase C activation in cultured granulosa cells. Molecular and Cellular Endocrinology 294:1-2, pages 52-60.
Crossref
Crossref
Suzanne D. Conzen. (2008) Minireview: Nuclear Receptors and Breast Cancer. Molecular Endocrinology 22:10, pages 2215-2228.
Crossref
Crossref
Yasir H. Ibrahim, Sara A. Byron, Xiaojiang Cui, Adrian V. Lee & Douglas Yee. (2008) Progesterone Receptor-B Regulation of Insulin-Like Growth Factor–Stimulated Cell Migration in Breast Cancer Cells via Insulin Receptor Substrate-2. Molecular Cancer Research 6:9, pages 1491-1498.
Crossref
Crossref
Weiyan Cai, Ying Zhu, Kishio Furuya, Zhen Li, Masahiro Sokabe & Ling Chen. (2008) Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology 55:2, pages 127-138.
Crossref
Crossref
Xiao-Dong Fu, Maria S. Giretti, Chiara Baldacci, Silvia Garibaldi, Marina Flamini, Angel Matias Sanchez, Angiolo Gadducci, Andrea R. Genazzani & Tommaso Simoncini. (2008) Extra-Nuclear Signaling of Progesterone Receptor to Breast Cancer Cell Movement and Invasion through the Actin Cytoskeleton. PLoS ONE 3:7, pages e2790.
Crossref
Crossref
Emily J. Faivre, Andrea R. Daniel, Christopher J. Hillard & Carol A. Lange. (2008) Progesterone Receptor Rapid Signaling Mediates Serine 345 Phosphorylation and Tethering to Specificity Protein 1 Transcription Factors. Molecular Endocrinology 22:4, pages 823-837.
Crossref
Crossref
Carol A LangeDouglas Yee. (2008) Progesterone and Breast Cancer. Women's Health 4:2, pages 151-162.
Crossref
Crossref
F. Stormshak & C. V. Bishop. (2008) BOARD-INVITED REVIEW: Estrogen and progesterone signaling: Genomic and nongenomic actions in domestic ruminants. Journal of Animal Science 86:2, pages 299-315.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 15:1, pages 79-111.
Crossref
Crossref
Carol A. Lange. (2008) Integration of progesterone receptor action with rapid signaling events in breast cancer models. The Journal of Steroid Biochemistry and Molecular Biology 108:3-5, pages 203-212.
Crossref
Crossref
Metodi Metodiev & Louise Alldridge. (2008) Phosphoproteomics: A possible route to novel biomarkers of breast cancer. PROTEOMICS – CLINICAL APPLICATIONS 2:2, pages 181-194.
Crossref
Crossref
Ana Rocha, Isabel Azevedo & Raquel Soares. (2008) Progesterone sensitizes breast cancer MCF7 cells to imatinib inhibitory effects. Journal of Cellular Biochemistry 103:2, pages 607-614.
Crossref
Crossref
Łukasz Wolański & Andrzej Stanisławek. (2008) The role of progesterone receptors in breast and endometrial cancerRola receptorów progesteronowych w raku gruczołu piersiowego i raku endometrium. Annales UMCS, Pharmacia 21:2, pages 299-307.
Crossref
Crossref
Carol A. Lange, Carol A. Sartorius, Hany Abdel-Hafiz, Monique A. Spillman, Kathryn B. Horwitz & Britta M. Jacobsen. 2008. Innovative Endocrinology of Cancer. Innovative Endocrinology of Cancer
94
111
.
Andrea R. Daniel, Emily J. Faivre & Carol A. Lange. (2007) Phosphorylation-Dependent Antagonism of Sumoylation Derepresses Progesterone Receptor Action in Breast Cancer Cells. Molecular Endocrinology 21:12, pages 2890-2906.
Crossref
Crossref
Stephen R. HammesEllis R. Levin. (2007) Extranuclear Steroid Receptors: Nature and Actions. Endocrine Reviews 28:7, pages 726-741.
Crossref
Crossref
Ana Rocha, Isabel Azevedo & Raquel Soares. (2007) Anti-angiogenic effects of imatinib target smooth muscle cells but not endothelial cells. Angiogenesis 10:4, pages 279-286.
Crossref
Crossref
Thomas Schlange, Yutaka Matsuda, Susanne Lienhard, Alexandre Huber & Nancy E Hynes. (2007) Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Research 9:5.
Crossref
Crossref
R. Sutherland & J. Scorer. (2007) Basic science (January 2007). Breast Cancer Online 10:5, pages 1-3.
Crossref
Crossref
M-A Forget, S Turcotte, D Beauseigle, J Godin-Ethier, S Pelletier, J Martin, S Tanguay & R Lapointe. (2007) The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. British Journal of Cancer 96:4, pages 646-653.
Crossref
Crossref
Andrea R. Daniel, Ming Qiu, Emily J. Faivre, Julie Hanson Ostrander, Andrew Skildum & Carol A. Lange. (2007) Linkage of progestin and epidermal growth factor signaling: Phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 72:2, pages 188-201.
Crossref
Crossref
Nancy L. Weigel & Nicole L. Moore. (2018) Kinases and protein phosphorylation as regulators of steroid hormone action. Nuclear Receptor Signaling 5:1, pages nrs.05005.
Crossref
Crossref